Charles River Laboratories International (MIL:1CRL) ROC (Joel Greenblatt) %: -0.67% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
70 GF Score
Price €143.90
GF Value €122.45
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International ROC (Joel Greenblatt) %?

Charles River Laboratories International MIL:1CRL 70 ROC (Joel Greenblatt) % is -0.67% as of Mar. 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 70/100 and a GF Value™ of €122.45. The stock has 8 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Charles River Laboratories International ranks worse than 50.24% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Charles River Laboratories International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -0.67%.

The historical rank and industry rank for Charles River Laboratories International's ROC (Joel Greenblatt) % or its related term are showing as below:

MIL:1CRL' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -3.02   Med: 36.34   Max: 41.4
Current: -3.02

During the past 13 years, Charles River Laboratories International's highest ROC (Joel Greenblatt) % was 41.40%. The lowest was -3.02%. And the median was 36.34%.

MIL:1CRL's ROC (Joel Greenblatt) % is ranked worse than
50.24% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02 vs MIL:1CRL: -3.02

Charles River Laboratories International's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -54.40% per year.


Charles River Laboratories International  (MIL:1CRL) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Charles River Laboratories International ROC (Joel Greenblatt) % Related Terms


Charles River Laboratories International ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Charles River Laboratories International's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charles River Laboratories International ROC (Joel Greenblatt) % Chart

Charles River Laboratories International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.70 40.83 35.72 10.80 0.35

Charles River Laboratories International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.40 19.55 22.50 -54.28 -0.67

MIL:1CRL vs RVTY, QGEN, ICLR: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Charles River Laboratories International ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's ROC (Joel Greenblatt) % falls into.


MIL:1CRL
70GF Score
Charles River Laboratories International Inc MIL:1CRL
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charles River Laboratories International ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(442.994 + 255.434 + 192.423) - (357.728 + 179.697 + 419.324)
=-65.898

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(443.523 + 311.16 + 205.007) - (437.992 + 168.095 + 339.967)
=13.636

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Charles River Laboratories International for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-11.072/( ( (1722.205 + max(-65.898, 0)) + (1581.215 + max(13.636, 0)) )/ 2 )
=-11.072/( ( 1722.205 + 1594.851 )/ 2 )
=-11.072/1658.528
=-0.67 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of -0.67% mean?
Charles River Laboratories International (MIL:1CRL) has a ROC (Joel Greenblatt) % of -0.67% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Charles River Laboratories International and its competitors. According to the industry distribution chart, Charles River Laboratories International ranks #106 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 50.2%.
Is Charles River Laboratories International's ROC (Joel Greenblatt) % too high?
Charles River Laboratories International's current ROC (Joel Greenblatt) % is -0.67%. Based on the distribution chart, Charles River Laboratories International ranks #106 out of 211 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's ROC (Joel Greenblatt) % compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #106 out of 211 companies for ROC (Joel Greenblatt) %. This places Charles River Laboratories International in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Charles River Laboratories International and its competitors. Charles River Laboratories International's current ROC (Joel Greenblatt) % is -0.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current ROC (Joel Greenblatt) % of -0.67%. The stock's GF Value™ is €122.45, compared to a current price of €143.90 — trading 17.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is -0.67%. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current ROC (Joel Greenblatt) % is -0.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 17.5% above its estimated GF Value™ of €122.45.

Key valuation signals for MIL:1CRL:

  • ROC (Joel Greenblatt) %: -0.67%
  • GF Value™: €122.45 vs. price of €143.90 (17.5% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for MIL:1CRL

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€122.45
GF Value